Methods: Sixty-four consecutive patients undergoing phacoemulsification were randomised to receive either diclofenac or no diclofenac in conjunction with cyclo pentolate 1% and phenylephrine 10% pre-operatively. Results: The two groups were statistically similar in age and sex. The mean pre-sclerostomy pupillary diameters were 8.1 mm in both groups. The mean post-phaco emulsification diameters were 7.6 mm in those receiving diclofenac and 7.2 mm in those not (p = 0.03). The mean diameters after infusion/aspiration were 7.7 mm in those receiving diclofenac and 7.1 mm in those not 
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PATIENTS AND METHODS
Sixty-four consecutive patients due to undergo routine phacoemulsification were enrolled into the study. Patients with diabetes or a past history of inflammatory eye disease were excluded. Pre-opera tively they were instilled with one drop of guttae This study shows that in the presence of irrigating solutions containing adrenaline, topical diclofenac has a statistically significant but clinically small additive effect in maintaining per-operative mydria sis.
